// App-Quantinova.ai

1528 : Prognostic Factors in Patients with HIV-Associated Hodgkin Lymphoma: An Analysis of 199 Cases

Researchers

Presenter

  • Jeremy S. Abramson

Principal Investigators

  • Brady E Beltran

  • Paula Y Tanaka

  • Julie M Vose

  • Jorge J Castillo

  • Michele Bibas

  • Mark Bower

  • Jaime Collins

  • Joseph M. Connors

  • Kate Cwynarski

  • Minh-Li Nguyen

  • Josep-Maria Ribera

Medical Centers

  • Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA

  • Clinical Department - Hematology., National Institute for Infectious Diseases, Rome, Italy

  • The Royal Marsden Hospital, London, United Kingdom

  • Medical Oncology, Chelsea & British Columbia Cancer Agency, Vancouver, BC, Canada

  • Hospital Nacional Guillermo Almenara, Lima, Peru

  • Oncology and Radiotherapy, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru

  • Instituto de Infectologia Emilio Ribas, Sao Paulo, Brazil

  • NCRI, London, United Kingdom

  • ICO- Hospital Germans Trias i Pujol. Jose Carreras Leukemia Research Institute and PETHEMA, GELTAMO, GELCAB and GESIDA groups., Badalona, Spain

Locations

  • Brazil

  • Canada

  • Italy

  • Spain

  • United Kingdom

  • United States

  • Peru

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Hodgkin's Lymphoma

  • Human immunodeficiency virus infection

  • Lymphomas

  • Acquired immunodeficiency syndrome

Biomarkers

  • Cluster of Differentiation 4

  • Granulocyte colony-stimulating factor

  • Human albumin

  • White Blood Cell

Drug/Treatment

  • dacarbazine Intravenous

  • Vinblastine

  • Doxorubicin

  • Bleomycin

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved